<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10" class="p">The ubiquitous prevalence of biofilms in nosocomial settings together with an alarming increase in microbial resistance to antibiotics have accelerated the search for new types of drugs and their suitable carriers. Herein we present data concerning the applicability of BC as a carrier for EOs â€“ antimicrobials with potential to fight against biofilm-based bone infections.</p>
